Personalized blood thinner choice after stent placement
Part of Heart & circulation clinical trials.
This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have had a drug-eluting heart stent placed about 9 to 15 months ago (12 months ± 3 months)
- Have at least one high-risk history such as recent heart attack symptoms, stroke history, poor circulation needing a procedure, heart failure, diabetes needing medication, or chronic kidney disease
- OR have a high-risk stent/lesion feature like left main disease, disease in 2–3 vessels, complex bifurcations needing 2+ stents, chronic total blockage, stent re-narrowing, graft-area problems, long or small-vessel blockages needing stents, or heavy calcification needing special treatment
- Be 80 years or younger
- Not be pregnant (and be willing/able to follow pregnancy-related rules)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether choosing blood thinners based on each person's needs works better than a standard approach after getting a heart stent. It aims to reduce risks like blood clots or bleeding.
This trial is testing a way to shorten the time you need to take blood thinners after getting a specific type of heart stent. It uses a special camera (OCT) inside the artery to help decide if stents are placed well enough to allow less time on dual antiplatelet therapy.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.